(HealthDay)—Curcumin can resensitize chemoresistant pancreatic ductal adenocarcinoma (PDAC) cells through inhibition of the polycomb repressive complex 2 (PRC2)-PVT1-c-Myc axis, according to a study published online July ...
Aug 2, 2017
0
1
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...
Jul 27, 2017
0
11
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania. Currently ...
Jul 12, 2017
0
142
Improving the quality and quantity of research into cancers with the poorest survival rates remains a key priority across all aspects of our research activity – from funding breakthroughs in biology, to growing a sustainable ...
Jun 21, 2017
1
1
Using the OncoArray genotyping platform developed by multiple cancer consortia, a recent large aggregated genomewide association study identifies new susceptibility loci for lung cancer, the leading cause of cancer mortality ...
Jun 13, 2017
0
1
Cancer pedigree analysis reveals the mutations in RB1 and TP53 genes play a key role in treatment-resistant, cancer cell-type transformation during EGFR inhibitor therapy for lung cancers.
Jun 7, 2017
0
1
Scientists say they've developed a new blood test for identifying pancreatic cancer—a step that might eventually allow earlier diagnosis.
May 24, 2017
0
151
New study findings link traveling to an academic medical center for surgical removal of pancreatic or thyroid cancer with higher quality surgical care for both cancers, and longer survival for patients with pancreatic cancer ...
May 1, 2017
0
0
A new study co-authored by a researcher starting her laboratory at the University of Kentucky Markey Cancer Center shows that in certain genetic situations, one non-small cell lung cancer subtype can change into another subtype.
Apr 14, 2017
0
34
(HealthDay)—There is a low risk of development of high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) among patients with Barrett's esophagus (BE) of
Apr 12, 2017
0
0
